Harvard Bioscience
HBIO
#9016
Rank
HK$0.68 B
Marketcap
HK$15.78
Share price
-6.45%
Change (1 day)
-58.69%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2024 (TTM): -HK$0.11 Billion

According to Harvard Bioscience's latest financial reports the company's current earnings are HK$97.73 Million. In 2023 the company made an earning of -HK$19.87 Million, an increase over its 2022 earnings that were of -HK$71.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.11 Billion424.68%
2023 -HK$19.87 Million-72.15%
2022 -HK$71.35 Million6456.43%
2021 -HK$1.09 Million-98.08%
2020 -HK$56.68 Million32.53%
2019 -HK$42.77 Million-31.01%
2018 -HK$61.99 Million243.9%
2017 -HK$18.03 Million-24.66%
2016 -HK$23.93 Million-14.69%
2015 -HK$28.05 Million-181.68%
2014 HK$34.33 M-9.97%
2013 HK$38.13 M120%
2012 HK$17.33 M-50.9%
2011 HK$35.3 M-52.51%
2010 HK$74.33 M-2.53%
2009 HK$76.26 M28.26%
2008 HK$59.45 M-20.05%
2007 HK$74.36 M13.96%
2006 HK$65.25 M17.59%
2005 HK$55.49 M57.37%
2004 HK$35.26 M-37.31%
2003 HK$56.24 M208.03%
2002 HK$18.25 M-168.71%
2001 -HK$26.58 Million-66.89%
2000 -HK$80.26 Million